Genome-wide identification of somatic aberrations from paired normal-tumor samples

Area of Science:

• Genomics
• Bioinformatics
• Cancer Research

Background:

• Genomic copy number alterations and allelic imbalance are key cancer features.
• Tumor complexity and normal cell contamination hinder SNP array analysis.
• Advances in genotyping technology enable deeper cancer genome research.

Purpose of the Study:

• To introduce GIANT, a bioinformatic tool for identifying somatic genomic aberrations from paired normal-tumor SNP array data.
• To accurately detect various aberrations in cancer genomes, including aneuploid samples with contamination.
• To enable the discovery of recurrent aberrations critical to tumorigenesis.

Main Methods:

• Developed GIANT, a bioinformatic tool for genome-wide somatic aberration identification.
• Incorporated genotype information from matched normal samples.
• Utilized statistical significance testing to identify recurrent aberrations.

Main Results:

• GIANT accurately detects genomic aberrations, including amplification, deletion, and loss of heterozygosity (LOH).
• The tool performs well on diverse datasets, including simulated data and cell line mixtures.
• GIANT can detect genomic aberrations at cancer cell proportions as low as 5-10%.

Conclusions:

• GIANT is a powerful bioinformatic tool for interpreting complex genomic aberrations in cancer.
• The tool assists in both academic cancer genome studies and clinical treatment strategies.
• GIANT provides a genome-wide profile of significant aberrations in tumor samples.